昆药集团
(600422)
| 流通市值：163.73亿 | | | 总市值：163.76亿 |
| 流通股本：7.57亿 | | | 总股本：7.57亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 959,830,112.81 | 1,493,010,312.73 | 1,125,189,467.52 | 1,238,593,366.08 |
| 应收票据及应收账款 | 3,060,579,414.12 | 2,734,001,981.76 | 2,890,454,208.97 | 2,791,218,771.6 |
| 其中：应收票据 | 74,290,183.84 | 183,003,996.74 | 81,339,256.4 | 111,045,124.9 |
| 应收账款 | 2,986,289,230.28 | 2,550,997,985.02 | 2,809,114,952.57 | 2,680,173,646.7 |
| 应收款项融资 | 180,130,172.5 | 160,699,628.48 | 141,060,359.84 | 176,333,106.97 |
| 预付款项 | 124,170,621.85 | 135,707,393.99 | 176,310,345.52 | 159,409,987.18 |
| 其他应收款合计 | 121,917,553.47 | 136,666,599.27 | 124,822,853.73 | 139,427,906.42 |
| 存货 | 1,786,507,593.86 | 1,688,247,280.29 | 1,671,555,652.11 | 1,792,927,007.04 |
| 其他流动资产 | 77,822,189.93 | 78,915,946.77 | 87,462,893.11 | 29,552,224.22 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,313,843,040.11 | 7,031,044,519.89 | 6,698,253,583.06 | 6,407,462,369.51 |
| 非流动资产: | | | | |
| 长期股权投资 | 23,747,839.49 | 23,790,872.85 | 23,560,651.5 | 23,826,776.66 |
| 其他权益工具投资 | 69,738,172.38 | 69,738,172.38 | 77,450,350.97 | 77,450,350.97 |
| 其他非流动金融资产 | 225,754,563.46 | 226,076,387.03 | 229,226,601.55 | 209,046,125.85 |
| 投资性房地产 | 22,364,210 | 22,576,253.36 | 22,788,296.75 | 23,000,340.1 |
| 固定资产 | 1,057,460,496.94 | 1,083,063,366.04 | 1,124,903,441.27 | 1,155,968,430.28 |
| 在建工程 | 104,677,458.67 | 95,840,159.11 | 93,511,921 | 75,829,813.03 |
| 使用权资产 | 62,656,710.94 | 69,786,184.5 | 40,706,937.91 | 41,361,109.59 |
| 无形资产 | 314,226,136.76 | 312,158,183.96 | 320,024,155.45 | 333,490,223.97 |
| 开发支出 | 204,011,155.6 | 213,334,732.36 | 211,951,667.92 | 192,863,077.59 |
| 商誉 | 91,727,481.11 | 91,727,481.11 | 91,727,481.11 | 91,727,481.11 |
| 长期待摊费用 | 21,727,674.6 | 22,188,810.72 | 20,339,894.89 | 22,859,991.52 |
| 递延所得税资产 | 271,798,443.38 | 262,616,900.75 | 273,983,755.96 | 272,053,837.92 |
| 其他非流动资产 | 37,090,247.27 | 41,441,249.11 | 62,100,865.55 | 98,789,151.5 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,506,980,590.6 | 2,534,338,753.28 | 2,592,276,021.83 | 2,618,266,710.09 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,820,823,630.71 | 9,565,383,273.17 | 9,290,529,604.89 | 9,025,729,079.6 |
| 流动负债: | | | | |
| 短期借款 | 738,276,676.44 | 725,487,434.36 | 663,731,262.87 | 526,681,997.77 |
| 应付票据及应付账款 | 1,060,108,120.79 | 932,690,575.72 | 901,949,024.21 | 924,338,879.89 |
| 其中：应付票据 | 239,882,129.71 | 267,979,261.94 | 207,234,096.92 | 172,730,912.14 |
| 应付账款 | 820,225,991.08 | 664,711,313.78 | 694,714,927.29 | 751,607,967.75 |
| 合同负债 | 80,294,593.67 | 90,603,919.57 | 87,572,210.22 | 90,885,488.9 |
| 应付职工薪酬 | 194,780,467.99 | 210,822,862.9 | 167,697,769.44 | 171,213,747.68 |
| 应交税费 | 214,742,585.88 | 214,953,339.22 | 247,366,870.96 | 176,178,567.08 |
| 其他应付款合计 | 1,439,340,166.13 | 1,391,833,230.19 | 1,321,823,257.38 | 1,435,994,111.3 |
| 应付股利 | - | - | - | 121,300,443.04 |
| 一年内到期的非流动负债 | 19,676,314.24 | 23,313,162.26 | 18,487,190.59 | 65,916,308.33 |
| 其他流动负债 | 50,245,451.05 | 54,554,303.14 | 42,735,998.95 | 32,742,113.18 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,797,464,376.19 | 3,644,258,827.36 | 3,451,363,584.62 | 3,423,951,214.13 |
| 非流动负债: | | | | |
| 长期借款 | 97,056,659.72 | 107,561,277.73 | 108,554,583.3 | 29,000,000 |
| 租赁负债 | 40,750,625.73 | 44,238,424.96 | 37,237,537.22 | 36,811,908.45 |
| 预计负债 | 44,396,312.47 | 44,396,312.47 | 34,692,616.57 | 34,692,616.57 |
| 递延收益 | 210,650,854.07 | 209,597,798.31 | 199,862,112.4 | 204,923,200.38 |
| 递延所得税负债 | 7,636,859.08 | 8,303,943.04 | 11,642,222.07 | 12,873,287.39 |
| 其他非流动负债 | 28,631,134.02 | 30,457,290.34 | 37,909,405.45 | 38,051,657.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 429,122,445.09 | 444,555,046.85 | 429,898,477.01 | 356,352,670.7 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,226,586,821.28 | 4,088,813,874.21 | 3,881,262,061.63 | 3,780,303,884.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 757,113,997 | 757,986,969 | 757,986,969 | 758,127,769 |
| 资本公积 | 1,149,507,339.14 | 1,157,501,133.18 | 1,158,720,749.63 | 1,160,186,805.73 |
| 减:库存股 | 1,552,618.62 | 10,419,384.66 | 10,419,384.66 | 11,849,488.56 |
| 其他综合收益 | -4,196,684.05 | -4,092,434.57 | 2,729,143.79 | 4,430,827.98 |
| 专项储备 | 2,484,185.93 | 2,484,185.93 | 2,484,185.93 | 2,484,185.93 |
| 盈余公积 | 376,659,653.21 | 376,659,653.21 | 355,389,859.8 | 355,389,859.8 |
| 未分配利润 | 3,136,017,414.82 | 3,017,323,960.27 | 2,979,921,398.27 | 2,817,261,117 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,416,033,287.43 | 5,297,444,082.36 | 5,246,812,921.76 | 5,086,031,076.88 |
| 少数股东权益 | 178,203,522 | 179,125,316.6 | 162,454,621.5 | 159,394,117.89 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,594,236,809.43 | 5,476,569,398.96 | 5,409,267,543.26 | 5,245,425,194.77 |
| 负债和股东权益合计 | 9,820,823,630.71 | 9,565,383,273.17 | 9,290,529,604.89 | 9,025,729,079.6 |
| 公告日期 | 2024-04-20 | 2024-03-22 | 2023-10-28 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |